• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动眼神经失用症的诊疗方法:基于遗传病因的综合征性诊疗方法。

Approach to Oculomotor Apraxia: A Syndromic Approach to Genetic Causes.

作者信息

Salari Mehri, Rezaei Kamran, Haghighatzadeh Mahsa, Mirabedini Maryam, Etemadifar Masoud

机构信息

Men's Health and Reproductive Health Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Science, Tehran, Iran.

出版信息

Cerebellum. 2025 Jun 17;24(4):116. doi: 10.1007/s12311-025-01869-0.

DOI:10.1007/s12311-025-01869-0
PMID:40526232
Abstract

BACKGROUND

Oculomotor apraxia (OMA), the clinical manifestation of impaired voluntary initiation of saccadic eye movements, has long been associated with several disorders and genetic mutations in the literature.

OBJECTIVES

The present study aims to review all the disorders and genetic mutations associated with OMA reported in the literature.

METHODS

PubMed, MEDLINE, Scopus, EMBASE, and Web of Science databases were systematically searched for related keywords, and related publications from January 2000 to January 2024 were reviewed.

RESULTS

All the disorders and genetic mutations presented with OMA in the literature were reported. Clinical manifestations of the congenital disorders- particularly members of autosomal recessive cerebellar ataxias- including Joubert syndrome, ataxia with oculomotor apraxia, ataxia-telangiectasia, and other disorders were discussed, Additionally, the pathophysiology of the genetic mutations in the anatomical pathway of OMA is discussed in this paper.

CONCLUSIONS

Most of the cases with OMA present this sign early in their disease course; thus, evaluating the possible differential diagnoses can guide clinicians to a more accurate diagnosis. Understanding the spectrum of disorders and clinical manifestations with OMA also provides valuable insights into further clinic-pathological and genetic evaluations of this clinical manifestation.

摘要

背景

眼球运动失用症(OMA)是眼球扫视运动自主启动受损的临床表现,长期以来在文献中一直与多种疾病和基因突变相关。

目的

本研究旨在回顾文献中报道的与OMA相关的所有疾病和基因突变。

方法

系统检索PubMed、MEDLINE、Scopus、EMBASE和Web of Science数据库中的相关关键词,并对2000年1月至2024年1月的相关出版物进行综述。

结果

报道了文献中所有出现OMA的疾病和基因突变。讨论了先天性疾病的临床表现,特别是常染色体隐性遗传性小脑共济失调的成员,包括Joubert综合征、伴有眼球运动失用症的共济失调、共济失调毛细血管扩张症和其他疾病。此外,本文还讨论了OMA解剖学通路中基因突变的病理生理学。

结论

大多数OMA病例在病程早期就出现此症状;因此,评估可能的鉴别诊断可指导临床医生做出更准确的诊断。了解OMA相关疾病谱和临床表现也为该临床表现的进一步临床病理和基因评估提供了有价值的见解。

相似文献

1
Approach to Oculomotor Apraxia: A Syndromic Approach to Genetic Causes.动眼神经失用症的诊疗方法:基于遗传病因的综合征性诊疗方法。
Cerebellum. 2025 Jun 17;24(4):116. doi: 10.1007/s12311-025-01869-0.
2
Validity and Reliability of the Turkish Version of the Dynamic Evaluation of Motor Speech Skill (DEMSS-TR) Test for Children With Speech Sound Disorders.土耳其语版运动性言语技能动态评估(DEMSS-TR)测试对语音障碍儿童的有效性和可靠性
Int J Lang Commun Disord. 2025 Jul-Aug;60(4):e70067. doi: 10.1111/1460-6984.70067.
3
Interventions for childhood apraxia of speech.儿童言语失用症的干预措施。
Cochrane Database Syst Rev. 2018 May 30;5(5):CD006278. doi: 10.1002/14651858.CD006278.pub3.
4
Interventions for eye movement disorders due to acquired brain injury.针对后天性脑损伤所致眼球运动障碍的干预措施。
Cochrane Database Syst Rev. 2018 Mar 5;3(3):CD011290. doi: 10.1002/14651858.CD011290.pub2.
5
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
8
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
9
Uncommon Non-MS Demyelinating Disorders of the Central Nervous System.中枢神经系统罕见的非多发性硬化脱髓鞘疾病
Curr Neurol Neurosci Rep. 2025 Jul 1;25(1):45. doi: 10.1007/s11910-025-01432-8.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.

本文引用的文献

1
Developmental, Cognitive, Ocular Motor, and Neuroimaging Findings Related to SUFU Haploinsufficiency: Unraveling Subtle and Highly Variable Phenotypes.与 SUFU 杂合性不足相关的发育、认知、眼球运动和神经影像学研究:揭示微妙且高度可变的表型。
Pediatr Neurol. 2024 Nov;160:38-44. doi: 10.1016/j.pediatrneurol.2024.07.015. Epub 2024 Jul 30.
2
Hematopoietic stem cell transplantation or enzyme replacement therapy in Gaucher disease type 3.戈谢病3型的造血干细胞移植或酶替代疗法。
Mol Genet Metab. 2024 Aug;142(4):108515. doi: 10.1016/j.ymgme.2024.108515. Epub 2024 Jun 13.
3
The atypical sphingolipid SPB 18:1(14Z);O2 is a biomarker for DEGS1 related hypomyelinating leukodystrophy.
非典型鞘脂 SPB 18:1(14Z);O2 是与 DEGS1 相关的脑白质营养不良的生物标志物。
J Lipid Res. 2023 Dec;64(12):100464. doi: 10.1016/j.jlr.2023.100464. Epub 2023 Oct 27.
4
Visual function in children with Joubert syndrome.杰特伯综合征患儿的视觉功能。
Dev Med Child Neurol. 2024 Mar;66(3):379-388. doi: 10.1111/dmcn.15732. Epub 2023 Aug 18.
5
Clinical and genetic characteristics of 36 children with Joubert syndrome.36例Joubert综合征患儿的临床和遗传特征
Front Pediatr. 2023 Jul 21;11:1102639. doi: 10.3389/fped.2023.1102639. eCollection 2023.
6
Teaching Video NeuroImage: Oculomotor Apraxia as the Only Presentation of Diffuse Intrinsic Pontine Glioma.教学视频神经影像:动眼神经失用作为弥漫性脑桥内生型胶质瘤的唯一表现
Neurology. 2023 Aug 22;101(8):e854-e855. doi: 10.1212/WNL.0000000000207376. Epub 2023 Apr 25.
7
Exome Analysis Reveals Novel Missense and Deletion Variants in the Gene as Causative of Joubert Syndrome.外显子组分析揭示基因中的新型错义变异和缺失变异是杰特综合征的致病原因。
Genes (Basel). 2023 Mar 28;14(4):810. doi: 10.3390/genes14040810.
8
The spectrum of neurological manifestations and genotype-phenotype correlation in Indian children with Gaucher disease.印度戈谢病患儿的神经学表现谱及基因型-表型相关性
Am J Med Genet A. 2023 Apr;191(4):1038-1043. doi: 10.1002/ajmg.a.63115. Epub 2023 Jan 13.
9
Ataxia with oculomotor apraxia type 2 caused by a novel homozygous mutation in SETX gene, and literature review.SETX基因新的纯合突变导致的2型动眼性失用共济失调及文献复习
Front Mol Neurosci. 2022 Nov 10;15:1019974. doi: 10.3389/fnmol.2022.1019974. eCollection 2022.
10
De novo heterozygous variants in SLC30A7 are a candidate cause for Joubert syndrome.SLC30A7 中的新生杂合变异是杰特综合征的候选病因。
Am J Med Genet A. 2022 Aug;188(8):2360-2366. doi: 10.1002/ajmg.a.62872. Epub 2022 Jun 25.